PPARA rs2854460: Metabolism and Aerobic Fitness
The rs2854460 single nucleotide polymorphism is an intronic variant located within the peroxisome proliferator-activated receptor alpha (PPARA) gene. Researchers have investigated this variant for its statistical associations with lipid substrate utilization and submaximal aerobic exercise capacity. Current scientific evidence connecting this specific marker to athletic performance and metabolic efficiency remains preliminary and limited.
What each genotype means
Typical lipid substrate utilization
This genotype represents the major allele combination for this variant. Research into this specific PPARA intron variant suggests it may play a role in how the body utilizes lipids during exercise, though current evidence regarding its impact on aerobic capacity remains limited and inconsistent. This result should not be used to predict athletic performance or guide training decisions.
Carried by approximately 64% of the global population based on a minor allele frequency of roughly 0.20.
Typical lipid substrate utilization
This heterozygous genotype includes one copy of the minor allele. While PPARA is a key regulator of lipid metabolism, the association between this specific variant and submaximal aerobic exercise capacity is not well-established. Individual fitness outcomes are complex and influenced by many genetic and environmental factors beyond this single marker.
Carried by approximately 32% of the global population.
Typical lipid substrate utilization
This genotype represents the homozygous minor allele state. While some studies investigate PPARA variants in the context of metabolic efficiency, the evidence linking this specific variant to exercise performance is limited and does not provide a clear clinical or athletic advantage. Please focus on established training and nutritional principles for your fitness goals.
Carried by approximately 4% of the global population.
Genetic Architecture and Variant Location
The single nucleotide polymorphism designated as rs2854460 is mapped to the PPARA gene on chromosome 22. It represents a non-coding variant situated within one of the gene's introns rather than in an exon that directly specifies amino acids. Because it resides in an intronic sequence, it does not alter the primary protein structure of the nuclear receptor. Instead, researchers hypothesize that such non-coding variants may subtly influence gene transcription efficiency, alter pre-mRNA splicing patterns, or simply act as a genetic surrogate marker in linkage disequilibrium with other nearby regulatory variants along chromosome 22.
The Biological Role of the PPARA Gene
The PPARA gene encodes peroxisome proliferator-activated receptor alpha, a ligand-activated transcription factor belonging to the nuclear hormone receptor superfamily. PPARA is prominently expressed in metabolically demanding tissues that rely heavily on fatty acid oxidation, including skeletal muscle, the liver, and the heart. Activated by endogenous ligands such as polyunsaturated fatty acids and their derivatives, PPARA coordinates the transcription of network genes responsible for cellular fatty acid uptake, intracellular lipid transport, mitochondrial beta-oxidation, and overall energy homeostasis during both fasting states and prolonged physical exertion.
Research on Exercise Capacity and Metabolism
In exercise physiology and sports genomics, variations across the PPARA locus have generated interest regarding individual differences in endurance capacity and substrate shifting. Studies focusing on variants like rs2854460 explore how subtle differences in receptor expression or regulation might influence the body's ability to prioritize fatty acid oxidation over glycogen stores during submaximal aerobic exercise. However, the available evidence specifically implicating rs2854460 remains limited. Most sports genomics cohorts involve small, specialized populations, and many candidate-gene associations have not achieved broad statistical confirmation across large, unbiased genome-wide association studies.
Population Distribution and Allele Patterns
Data from large-scale reference datasets such as the Genome Aggregation Database (gnomAD) indicate that rs2854460 is a common polymorphism globally. The minor allele has an overall global frequency of approximately 0.20, meaning that roughly one in five chromosomes in the world population carries it. While commonly observed across multiple ancestral groups, allele frequencies can exhibit mild fluctuations among continental populations, including European, African, and Asian ancestries. Having a minor allele at this frequency is considered a standard physiological variation within healthy human diversity.
Practical Interpretation and Actionability
Knowledge of your rs2854460 genotype provides interesting biological insight into your inherited metabolic framework, but it is not a diagnostic tool or a predictive determinant of physical fitness. Complex physical traits such as aerobic endurance, maximal oxygen uptake (VO2 max), and fat oxidation rates are highly polygenic and heavily driven by regular training, balanced nutrition, recovery habits, and overall lifestyle. Genotype results should never be used to limit fitness aspirations or justify radical dietary alterations without guidance from qualified health and exercise professionals.
How common is this variant?
The rs2854460 variant is common across global populations, with a minor allele frequency of approximately 0.20 according to reference data in gnomAD.
Frequently asked questions
Does having the rs2854460 variant guarantee superior endurance fitness?
No. Aerobic capacity and endurance performance depend on thousands of genetic variants working in synergy, alongside essential factors like structured physical training, diet, rest, and sleep. A single variant in PPARA provides only minor, statistical background variance rather than a deterministic outcome.
Can my rs2854460 genotype dictate my optimal diet?
No, current nutritional genomics does not support making drastic changes to your diet based solely on an intronic variant in PPARA. General nutritional principles—such as consuming a well-rounded diet with adequate quality protein, complex carbohydrates, and healthy fats—remain the foundation of performance and health.
Is the rs2854460 variant linked to any genetic disease?
No, rs2854460 is not recognized in clinical databases as a cause of monogenic disease. It is a common benign polymorphism evaluated strictly in the context of normal physiological variation, metabolic efficiency, and polygenic exercise response.
How strong is the scientific evidence for this variant?
The evidence linking rs2854460 to exercise performance and lipid oxidation is classified as limited. Candidate gene studies often yield conflicting results or small effect sizes that require further confirmation through large, multi-ancestry genome-wide association studies.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2854460?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PPARA
The PPARA Leu162Val missense substitution modulates fasting triglyceride levels and individual lipid responses to dietary polyunsaturated fatty acid (PUFA) intake.
The Leu162Val variant in PPARA modulates lipid response and triglyceride clearance in response to dietary PUFA intake.
The PPARA Leu162Val polymorphism modulates fasting triglyceride and cholesterol responses to dietary polyunsaturated fatty acid (PUFA) intake.
Intronic regulatory polymorphism in PPARA associated with lipid metabolism and cardiovascular fitness profiles.
Influences PPARA expression and is associated with variations in cholesterol levels and response to dietary fat intake.
This SNP is associated with the capacity to improve VO2max in response to endurance training and metabolic efficiency.